GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Wuhan Easy Diagnosis Biomedicine Co Ltd (SZSE:002932) » Definitions » Price-to-Operating-Cash-Flow

Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) Price-to-Operating-Cash-Flow : 5.77 (As of May. 24, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Wuhan Easy Diagnosis Biomedicine Co Price-to-Operating-Cash-Flow?

As of today (2024-05-24), Wuhan Easy Diagnosis Biomedicine Co's share price is ¥18.99. Wuhan Easy Diagnosis Biomedicine Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥3.29. Hence, Wuhan Easy Diagnosis Biomedicine Co's Price-to-Operating-Cash-Flow Ratio for today is 5.77.

The historical rank and industry rank for Wuhan Easy Diagnosis Biomedicine Co's Price-to-Operating-Cash-Flow or its related term are showing as below:

SZSE:002932' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 1.84   Med: 15.2   Max: 155.75
Current: 5.76

During the past 13 years, Wuhan Easy Diagnosis Biomedicine Co's highest Price-to-Operating-Cash-Flow Ratio was 155.75. The lowest was 1.84. And the median was 15.20.

SZSE:002932's Price-to-Operating-Cash-Flow is ranked better than
92.26% of 439 companies
in the Medical Devices & Instruments industry
Industry Median: 20.88 vs SZSE:002932: 5.76

Wuhan Easy Diagnosis Biomedicine Co's Cash Flow from Operations per share for the three months ended in Mar. 2024 was ¥0.20. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥3.29.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Wuhan Easy Diagnosis Biomedicine Co was -76.50% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 0.10% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 104.70% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 37.50% per year.

During the past 13 years, Wuhan Easy Diagnosis Biomedicine Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 444.80% per year. The lowest was -34.30% per year. And the median was 0.90% per year.


Wuhan Easy Diagnosis Biomedicine Co Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Wuhan Easy Diagnosis Biomedicine Co's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuhan Easy Diagnosis Biomedicine Co Price-to-Operating-Cash-Flow Chart

Wuhan Easy Diagnosis Biomedicine Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 107.87 11.76 6.25 2.20 13.29

Wuhan Easy Diagnosis Biomedicine Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.65 2.31 2.61 13.29 6.62

Competitive Comparison of Wuhan Easy Diagnosis Biomedicine Co's Price-to-Operating-Cash-Flow

For the Medical Devices subindustry, Wuhan Easy Diagnosis Biomedicine Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wuhan Easy Diagnosis Biomedicine Co's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Wuhan Easy Diagnosis Biomedicine Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Wuhan Easy Diagnosis Biomedicine Co's Price-to-Operating-Cash-Flow falls into.



Wuhan Easy Diagnosis Biomedicine Co Price-to-Operating-Cash-Flow Calculation

Wuhan Easy Diagnosis Biomedicine Co's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=18.99/3.292
=5.77

Wuhan Easy Diagnosis Biomedicine Co's Share Price of today is ¥18.99.
Wuhan Easy Diagnosis Biomedicine Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥3.29.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Wuhan Easy Diagnosis Biomedicine Co Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Wuhan Easy Diagnosis Biomedicine Co's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Dongxin Road, 2 Floor, Building E, International Students Pioneer Park, Guandong Science and Technology Park, Donghu Development Zone, Hubei, Wuhan, CHN, 430075
Wuhan Easy Diagnosis Biomedicine Co Ltd is engaged in the research and development, production and sales of in vitro diagnostic reagents and supporting instruments and mobile ECG products. The company's product profile consists of Molecular diagnosis, Chemiluminescence, Blood gas analysis, and others. It also provides various other solutions such as Mingde Biomolecular Diagnostic Service Solution, Mingde Biothoracic Center Solution, POCT Solution, Remote ECG network construction solution, and others.
Executives
Wang Rui Directors, executives
Wang Jian Fei Director

Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) Headlines

No Headlines